Cubresa Inc.

Cubresa develop and market preclinical PET and SPECT nuclear imaging products to allow researchers at leading hospitals, universities and pharmaceutical companies to non-invasively visualize and measure biochemical processes at the molecular level.

Applications for their products include preclinical drug development and disease research in oncology, neurological, and cardiovascular areas. Their multimodal preclinical in vivo imaging products feature ultra-compact scanner footprints and excellent resolution, sensitivity and image quality.